Domestic price of Sonidegib
Patients with advanced basal cell carcinoma (BCC) have very limited treatment options. Sonidegib (Sonidegib) selectively inhibits the growth of Hedgehog pathway-dependent tumors and can treat patients with locally advanced basal cell carcinoma who are not suitable for surgery or radiotherapy. The BOLT clinical trial is designed to evaluate the efficacy/potential of solidegib in the treatment of advanced basal cell carcinoma or metastatic basal cell carcinoma.

These patients were randomized in a 1:2 ratio to receive 200 or 800 mg of oral solidegib daily. The primary efficacy analysis showed that 18 patients in the 200 mg group and 35 patients in the 800 mg group demonstrated objective response, corresponding to 43% and 38% of the respective categories, respectively. Among patients who took 200 and 800 mg solidegib, 93% and 80% of patients respectively had their disease controlled. The most common adverse events were muscle cramps, alopecia, dysgeusia, nausea, elevated blood creatine kinase, andfatigue. In contrast, patients who took 200 mg of Solidagib experienced fewer adverse events than those who took 800 mg of Solidagib. Therefore, the benefits of using the 200 mg dose of Solidagib outweigh the associated risks, and it can be concluded that it would be prudent to choose a lower intensity dose.
Solidagen is a new type of drug for treating diseases. Although the original drug Solidagen has been launched in China, it has not yet entered the scope of medical insurance. Its price has not yet been determined, and domestic patients cannot yet purchase this drug. The price of Solidegib Original drug, European version specifications200mg*30 capsules per box listed overseas is around RMB 46,000 (the price may fluctuate due to the exchange rate), which is relatively expensive. The ingredients of the two drugs are basically the same. When purchasing this drug overseas, you need to choose through formal channels. Currently, there are no generic drugs of Solidagen produced and put on the market. For specific price and drug information, please consult Yaode Medical Consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)